Oral rather than intravenous corticosteroids should be used to treat MS relapses - Yes

Emmanuelle Le Page (1, 2) , Gilles Edan (3, 2, 1)

1 CIC - Centre d'Investigation Clinique [Rennes]
2 Service de Neurologie [Rennes] = Neurology [Rennes]
3 VisAGeS - Vision, Action et Gestion d'informations en Santé

The therapeutic arsenal for preventing multiple sclerosis (MS) relapses strongly improved over the last 20 years with more than 10 disease-modifying drugs now available. However, relapses can still occur, requiring treatment with corticosteroids to accelerate recovery...

Domaines: Sciences du Vivant [q-bio]

Emmanuelle Le Page, Gilles Edan. Oral rather than intravenous corticosteroids should be used to treat MS relapses - Yes. Multiple Sclerosis Journal, 2017, 23 (8), pp.1056--1058. ⟨10.1177/1352458517695893⟩. ⟨hal-01559941⟩